ストックスクリーナーアプリを入手
14.65
0.34%
-0.05
プレマーケット:
14.96
0.31
+2.12%
前日終値:
$14.70
開ける：
$14.8
24時間の取引高:
2.14M
Relative Volume:
1.13
時価総額：
$1.77B
収益：
$631.73M
当期純損益:
$-239.78M
株価収益率:
-7.2525
EPS:
-2.02
ネットキャッシュフロー:
$-33.45M
1週間 パフォーマンス:
-2.85%
1か月 パフォーマンス:
-7.98%
6か月 パフォーマンス:
-22.36%
1年 パフォーマンス:
-68.01%
1日の値動き範囲:
$14.53
$15.08
1週間の範囲:
$14.01
$15.50
52週間の値動き範囲:
$12.95
$51.22
10 X Genomics Inc Stock (TXG) Company Profile
名前
10 X Genomics Inc
セクター
電話
(925) 401-7300
住所
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
TXG を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TXG
10 X Genomics Inc
|
14.65 | 1.77B | 631.73M | -239.78M | -33.45M | -2.02 |
|
VEEV
Veeva Systems Inc
|
239.43 | 38.87B | 2.66B | 665.91M | 1.08B | 4.05 |
|
SOLV
Solventum Corp
|
74.78 | 12.92B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
58.26 | 10.88B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
64.99 | 10.23B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
112.07 | 9.71B | 1.15B | 96.70M | -161.99M | 1.09 |
10 X Genomics Inc Stock (TXG) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-09-03 | 開始されました | Leerink Partners | Outperform |
| 2024-07-22 | アップグレード | Jefferies | Hold → Buy |
| 2024-07-18 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-07-10 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2024-06-27 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2024-06-25 | ダウングレード | Guggenheim | Buy → Neutral |
| 2024-06-03 | 再開されました | Jefferies | Hold |
| 2024-05-01 | ダウングレード | TD Cowen | Buy → Hold |
| 2023-12-14 | 開始されました | Guggenheim | Buy |
| 2023-12-13 | 開始されました | Wolfe Research | Outperform |
| 2023-12-12 | アップグレード | BofA Securities | Underperform → Neutral |
| 2023-07-05 | 再開されました | JP Morgan | Overweight |
| 2023-05-10 | 開始されました | Barclays | Overweight |
| 2023-03-31 | 開始されました | Stephens | Overweight |
| 2023-02-02 | 開始されました | UBS | Neutral |
| 2022-12-14 | 開始されました | Deutsche Bank | Buy |
| 2022-08-18 | ダウングレード | Goldman | Neutral → Sell |
| 2022-07-25 | 開始されました | Canaccord Genuity | Buy |
| 2022-07-15 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2022-07-15 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-09-14 | ダウングレード | BofA Securities | Buy → Neutral |
| 2021-03-15 | 開始されました | William Blair | Outperform |
| 2020-12-02 | 開始されました | Goldman | Neutral |
| 2020-09-09 | 開始されました | Morgan Stanley | Overweight |
| 2020-07-10 | 開始されました | Stifel | Buy |
| 2020-03-05 | 開始されました | Guggenheim | Buy |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2019-10-07 | 開始されました | BofA/Merrill | Buy |
| 2019-10-07 | 開始されました | Cowen | Outperform |
| 2019-10-07 | 開始されました | JP Morgan | Overweight |
| 2019-09-24 | 開始されました | Evercore ISI | Outperform |
すべてを表示
10 X Genomics Inc (TXG) 最新ニュース
10x Genomics, Inc. (TXG): Among Cathie Wood’s Top Stock Picks for 2025 - Yahoo Finance
10x, Harvard settle genomics patent dispute with Vizgen during trial - Reuters
10x Genomics, Harvard settle Vizgen patent dispute (TXG:NASDAQ) - Seeking Alpha
22,687 Shares in 10x Genomics, Inc. (NASDAQ:TXG) Acquired by China Universal Asset Management Co. Ltd. - MarketBeat
Chan Zuckerberg Initiative Launches Billion Cells Project with 10x Genomics and Ultima Genomics to Advance AI in Biology – Company AnnouncementFT.com - Financial Times
10x Genomics (TXG) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance
Seattle's Parse Biosciences lands another legal victory in patent dispute - The Business Journals
Parse Wipes Out 10x Genomics Patents Ahead of March Trial - Bloomberg Law
Cathie Wood's ARK buys Qualcomm and 10X Genomics stock - MSN
SG Americas Securities LLC Acquires 49,468 Shares of 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat
10 Promising Biotech Stocks to Invest in (February 2025) - Securities.io
Slow Capital Inc. Has $310,000 Position in 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat
Genomics Market to Grow by USD 5.21 Billion (2024-2028), Boosted by Rising Investments in R&D, with AI Impacting Market TrendsTechnavio - Yahoo Finance
[Latest] Global Single Cell Multiomics Market Size/Share Worth USD 18.90 Billion by 2033 at a 19.58% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value) - GlobeNewswire Inc.
After a Year of Launches, 10x Refocuses on Customer Support, Biopharma Market Growth - Genetic Engineering & Biotechnology News
10x Genomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 12, 2025 - BioSpace
10x Genomics, Inc. (NASDAQ:TXG) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
TXG (10x Genomics) EV-to-EBIT : -8.44 (As of Jan. 24, 2025) - GuruFocus.com
10x Genomics (MEX:TXG) EV-to-EBITDA : -13.26 (As of Jan. 24, 2025) - GuruFocus.com
10x Genomics (NASDAQ:TXG) Shares Down 10%Here's Why - MarketBeat
Spatial Proteomics Market Report and Competitive Landscape 2025-2030, with 10X Genomics, Bruker, Fluidigm, Akoya Biosciences, PerkinElmer, Biotechne, S2 Genomics, Seven Bridges Genomics & More - Yahoo Finance
Weiss Ratings Reaffirms Sell (E+) Rating for 10x Genomics (NASDAQ:TXG) - MarketBeat
TXG (10x Genomics) Preferred Stock : $0.0 Mil (As of Sep. 2024) - GuruFocus.com
Avanza Fonder AB Takes Position in 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat
TXG (10x Genomics) Future Policy Benefits - GuruFocus.com
TXG (10x Genomics) EBIT per Share : $-1.47 (TTM As of Sep. 2024) - GuruFocus.com
TXG (10x Genomics) Shareholder Yield % : 0.44% (As of Sep. 2024) - GuruFocus.com
TXG (10x Genomics) Earnings Yield (Joel Greenblatt) % : -7.27% (As of Sep. 2024) - GuruFocus.com
10x Genomics (NASDAQ:TXG) Trading Down 4.9%What's Next? - MarketBeat
Assenagon Asset Management S.A. Makes New $26.31 Million Investment in 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat
10x Genomics (FRA:1KJ) Days Sales Outstanding : 53.41 (As of Sep. 2024) - GuruFocus.com
Mirador Capital Partners LP Boosts Position in 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat
The Analyst Verdict: 10x Genomics In The Eyes Of 6 Experts - Benzinga
JPMorgan Chase & Co. Has $8.03 Million Stock Holdings in 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat
10x Genomics (NASDAQ:TXG) Shares Gap UpTime to Buy? - MarketBeat
Morgan Stanley Issues Pessimistic Forecast for 10x Genomics (NASDAQ:TXG) Stock Price - MarketBeat
10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2024 Results - The Malaysian Reserve
10x Genomics Q4 Revenue Hits $165M with Mixed Results: Services Surge 35% YoY Despite Overall Decline - StockTitan
Diversified Trust Co Invests $511,000 in 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat
10x Genomics Announces Mega-Scale Single Cell Analysis for One Cent Per Cell at Human Cell Atlas General Meeting - Kilgore News Herald
10x Genomics: Struggling Amid Operational Challenges (NASDAQ:TXG) - Seeking Alpha
Vizgen's Antitrust Claims Tossed From 10x, Harvard Patent Suit - Bloomberg Law
Vizgen Loses Antitrust Claims Against 10x In Biotech IP Fight - Law360
10x Genomics (NASDAQ:TXG) Shares Up 11.6%Here's What Happened - MarketBeat
10x Genomics to Present at the 43rd Annual J.P. Morgan Healthcare Conference - StreetInsider.com
10x Genomics to Present at the 43rd Annual J.P. Morgan Healthcare Conference – Company Announcement - Financial Times
10x Genomics, Inc. (NASDAQ:TXG) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Cathie Wood's ARK ETF adjusts, adds 10X Genomics, sells Rocket Lab - Investing.com
10 X Genomics Inc (TXG) 財務データ
収益
当期純利益
現金流量
EPS
8.82%
3.54%
大文字化:
|
ボリューム (24 時間):